Cheshire, UK -- (MARKET WIRE) -- February 26, 2007 --
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 26 February 2007 - Protherics PLC ("Protherics"
or the "Company"), the international biopharmaceutical company focused on
critical care and cancer, announces that the following notification of interest
in the ordinary share capital of the Company was received on 23 February 2007
from AMVESCAP PLC.
1. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights x
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):___________________________________________
2. Full name of person(s) subject to the AMVESCAP PLC
notification obligation:
3. Full name of shareholder(s) (if different from 2.):
4. Date of the transaction (and date on which the 20 February 2007
threshold is crossed or reached if different):
5. Date on which issuer notified: 21 February 2007
6. Threshold(s) that is/are crossed or reached: 10%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
Ordinary Shares 30,886,678 30,886,678 35,740,354 35,740,354 10.54%
2p
GB0007029209
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting
instrument Period/ Date that may be acquired if rights
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
35,740,354 10.54%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Chase Nominees - 7,520,443
Vidacos Nominees - 28,104,599
Northern Trust Company (London) - 115,312
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange